A recent study speculates that the proteoglycan syndecan-1 (Sdc-1), whose expression is regulated by intracellular targets of the GLP-1 receptor (GLP-1R), modulates pro-inflammatory processes, and has a protective role in AAA (147). Here, GLP1R is linked to triple-A syndrome.